基因套組市場規模、佔有率、成長分析、按產品/服務、按方法、按設計、按地區 - 產業預測，2024-2031年

2022年全球基因套組市場規模為24億美元，預計從2023年的28.6億美元成長到2031年的117.5億美元，將以19.30%的年複合成長率成長。

個人化醫療和基因技術的快速發展顯著推動全球基因套組市場的成長。隨著基因套組序列測定成本的下降，基因套組變得越來越便宜，能夠對多種疾病進行全面的基因檢測和分析。遺傳疾病盛行率的上升以及對精確和客製化治療策略的需求不斷成長推動這一市場的擴張。基因套組提供了有關遺傳傾向和潛在治療途徑的重要見解，增強了在研究、診斷和治療開發中的應用。這些面板由大量分析的精選基因集合組成，用於檢測與各種疾病相關的遺傳變異，可以同時高效且有針對性地詢問多個基因。這種能力不僅有助於揭示遺傳疾病，而且有助於制定量身定做的治療計劃。在生物資訊學和定序技術持續創新的推動下，基因套組的未來看起來充滿希望，預計這些技術將提高其準確性並擴大其臨床效用。隨著基因套組擴大融入標準臨床實踐並擴大用於治療和預防，其在個人化醫療領域的重要性不斷成長，這將為醫療保健領域的開發和應用帶來重大機會。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 依細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 抑制因素和挑戰
• 波特分析與影響
  • 競爭公司之間的敵對關係
  • 替代品的威脅
  • 買方議價能力
  • 新進入者的威脅
  • 供應商的議價能力

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 技術進步
• 監管環境
• 專利分析
• 價值鏈分析
• 案例研究分析
• PESTEL分析
• 總體經濟指標
• 價格分析

基因套組市場：依產品/服務分類

• 檢測套組
• 檢驗服務

基因套組市場：依方法論

• 基於擴增子的方法
• 基於混合的方法

基因套組市場：依設計設計

• 預先設計的基因套組
• 客製化基因套組

基因套組市場：依應用分類

• 癌症風險評估
  • 特定綜合症
  • 高滲透性
  • 高、中滲透率
  • 整體癌症風險
• 先天性疾病的診斷
• 藥物基因學
• 其他用途

基因套組市場：依最終用途分類

• 研究/學術機構
• 醫院和診斷實驗室
• 製藥和生物技術公司

基因套組市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東、非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 依細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• Qiagen
• Roche
• Illumina
• Thermo Fisher Scientific
• Agilent Technologies
• Bio-Rad Laboratories
• PerkinElmer
• Becton, Dickinson and Company（BD）
• Sangamo Therapeutics

Global Gene Panel Market size was valued at USD 2.40 Billion in 2022 poised to grow from USD 2.86 Billion in 2023 to USD 11.75 Billion by 2031, growing at a CAGR of 19.30% in the forecast period (2024-2031).

The rapid advancements in personalized medicine and genetic technologies are significantly driving the growth of the global gene panel market. As genomic sequencing costs decline, gene panels have become increasingly affordable, enabling comprehensive genetic testing and analysis for a wide range of diseases. The rising prevalence of hereditary conditions and the growing demand for precise, tailored treatment strategies fuel this market expansion. Gene panels provide critical insights into genetic predispositions and potential treatment pathways, enhancing their application in research, diagnostics, and therapeutic development. These panels consist of a curated collection of genes analyzed collectively to detect genetic variations associated with various disorders, allowing for efficient and targeted investigations of multiple genes simultaneously. This capability not only elucidates hereditary diseases but also fosters the creation of customized treatment plans. The future of gene panels appears promising, bolstered by ongoing innovations in bioinformatics and sequencing technologies that are expected to enhance their accuracy and broaden their clinical utility. As gene panels become increasingly integrated into standard clinical practice and expand their use in both therapeutic and preventive contexts, their significance in the realm of personalized medicine will continue to grow, presenting vast opportunities for development and application in the healthcare sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Gene Panel market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Gene Panel Market Segmental Analysis

Global Gene Panel Market is segmented by Product and Services, Technique, Design, Application, End User and Region. Based on Product and Services, the market is segmented into Test Kits, and Testing Services. Based on Technique, the market is segmented into Amplicon-based Approach, and Hybridization-based Approach. Based on Design the market is segmented into Predesigned Gene Panel, and Customized Gene Panel. Based on Application, the market is segmented into Cancer Risk Assessment, Diagnosis of Congenital Diseases, and Pharmacogenetics. Based on end user, the market is segmented into Research and Academic Institutes, Hospital and Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Gene Panel Market

The global gene panel market is significantly propelled by advancements in next-generation sequencing (NGS) technologies, which enhance precision, speed, and cost-efficiency in genetic analyses. These innovations facilitate comprehensive genomic profiling, thereby enabling personalized medicine tailored to individual genetic profiles. As healthcare increasingly shifts towards targeted therapies and precision diagnostics, the demand for gene panels in both clinical and research settings is rising sharply. Additionally, the ability of NGS to process large amounts of genetic information quickly allows for more effective disease diagnosis and treatment plans, further fueling market growth and attracting investments in genetic research and healthcare innovations.

Restraints in the Global Gene Panel Market

A significant restraint for the global gene panel market is the limited knowledge and understanding among healthcare professionals and patients regarding gene panel testing. Many individuals may not be aware of the advantages and applications of DNA panels, which can hinder their willingness to pursue genetic testing. This lack of education can result in skepticism or misconceptions about the value and utility of gene panels, ultimately slowing down adoption rates. Consequently, the limited awareness diminishes the perceived benefits of genetic testing, thus affecting market expansion and stifling the potential advancements that gene panel technology could offer in personalized medicine and tailored healthcare solutions.

Market Trends of the Global Gene Panel Market

The global gene panel market is experiencing significant growth driven by a marked surge in the adoption of personalized medicine. As healthcare practitioners increasingly leverage gene panels for tailored treatment regimens, this trend emphasizes the importance of precision diagnostics and targeted therapies. Advancements in genomics, particularly in next-generation sequencing technologies, have played a pivotal role in enhancing the accuracy and efficiency of genetic testing, enabling clinicians to make more informed decisions about patient care. Consequently, this shift towards personalized healthcare is not only improving patient health outcomes but also catalyzing demand for innovative gene panel products, positioning the market for substantial expansion.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Value Chain Analysis
• Case Study Analysis
• PESTEL Analysis
• Macro-Economic Indicators
• Pricing Analysis

Global Gene Panel Market Size by Product and Service & CAGR (2024-2031)

• Test Kits
• Testing Services

Global Gene Panel Market Size by Technique & CAGR (2024-2031)

• Amplicon-based Approach
• Hybridization-based Approach

Global Gene Panel Market Size byDesign & CAGR (2024-2031)

• Predesigned Gene Panel
• Customized Gene Panel

Global Gene Panel Market Size byApplication & CAGR (2024-2031)

• Cancer Risk Assessment
  • Syndrome-specific
  • High-penetrance
  • High and Moderate-penetrance
  • Comprehensive Cancer Risk
• Diagnosis of Congenital Diseases
• Pharmacogenetics
• Other Applications

Global Gene Panel Market Size by End-use & CAGR (2024-2031)

• Research and Academic Institutes
• Hospital and Diagnostic Laboratories
• Pharmaceutical and Biotechnology Companies

Global Gene Panel Market Size & CAGR (2024-2031)

• North America, (Product and Services, Technique, Design, Application, End User)
  • US
  • Canada
• Europe, (Product and Services, Technique, Design, Application, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Product and Services, Technique, Design, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Product and Services, Technique, Design, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Product and Services, Technique, Design, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Qiagen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sangamo Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates